CADL
Candel Therapeutics Inc
NASDAQ: CADL · HEALTHCARE · BIOTECHNOLOGY
$6.18
-0.32% today
Updated 2026-04-29
Market cap
$476.11M
P/E ratio
—
P/S ratio
436.42x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$4 – $8
Volume
1.6M
Candel Therapeutics Inc (CADL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-64.60%
ROA
-26.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $125000.00 | $-8.24M | -5,185.60% | -7,229.60% | -6,592.00% |
| 2020 | $125000.00 | $-17.68M | 100.00% | -11,048.00% | -14,144.00% |
| 2021 | $125000.00 | $-36.12M | 100.00% | -20,580.80% | -28,899.20% |
| 2022 | $125000.00 | $-18.79M | 100.00% | -27,777.60% | -15,035.20% |
| 2023 | $31000.00 | $-37.94M | -77,354.84% | -123,841.94% | -122,383.87% |
| 2024 | $0.00 | $-55.18M | — | — | — |
| 2025 | $0.00 | $-38.18M | — | — | — |